None
Quote | Vaccinex Inc. (NASDAQ:VCNX)
Last: | $7.40 |
---|---|
Change Percent: | -0.67% |
Open: | $8.11 |
Close: | $7.45 |
High: | $8.11 |
Low: | $7.29 |
Volume: | 17,164 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Vaccinex Inc. (NASDAQ:VCNX)
2024-03-27 08:38:18 ET More on Vaccinex Financial information for Vaccinex Read the full article on Seeking Alpha For further details see: Vaccinex to raise $1.5M through in a direct offering
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease and cancer through the inhibition of SEMA...
Message Board Posts | Vaccinex Inc. (NASDAQ:VCNX)
Subject | By | Source | When |
---|---|---|---|
Taking a dip lower premarket | harry crumb | investorshub | 02/08/2023 12:52:46 PM |
Need more volumn | harry crumb | investorshub | 02/07/2023 3:52:50 PM |
5@ 100% runs in past, patent news should | 81vette | investorshub | 02/07/2023 3:41:37 PM |
near bottom here MAs curving up,looking for dbl | 81vette | investorshub | 02/07/2023 3:13:00 PM |
258Xs ave vol,big $ buying,institutions like patent news | 81vette | investorshub | 02/07/2023 3:05:47 PM |
News, Short Squeeze, Breakout and More Instantly...
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease and cancer through the inhibition of SEMA...
2024-03-08 11:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb® Drug Discovery Platform ActivMab® platform enable...